Intellia Therapeutics Aktie
13,31
EUR
+2,37
EUR
+21,62
%
15,93
USD
+3,53
USD
+28,47
%
Werbung
Intellia Therapeutics Aktie Analyse
02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung